IMCC
IM Cannabis Corp.
There isn't enough reported data to score IMCC yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
IMCC Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Weak |
IMCC's revenue, profitability, cash flow and balance sheet are all currently weak.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
IMCC PE Valuation
IMCC has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
IMCC Forward outlook
There aren't enough analyst estimates for IMCC to show an outlook.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
IMCC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2020 | -$629.57 | -$607.83 |
IMCC lost $629.57 per share over the past year, a bigger loss than the year before.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over IMCC in the latest year-over-year earnings comparison.
IMCC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $5.3M | -40% |
| Q1 2026 | $6.1M | -31% |
| Q4 2025 | $7.9M | -16% |
| Q3 2025 | $9.7M | -0.2% |
| Q2 2025 | $8.9M | -14% |
| Q1 2025 | $8.8M | +3.6% |
| Q4 2024 | $9.4M | +25% |
| Q3 2024 | $9.8M | +12% |
IMCC's revenue has slid since its 2024 peak: $5M last quarter, down 40% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -28% | -25 points |
| Q1 2026 | -19% | -21 points |
| Q4 2025 | -25% | +123 points |
| Q3 2025 | -30% | -37 points |
| Q2 2025 | -2.8% | -22 points |
| Q1 2025 | 1.3% | +48 points |
| Q4 2024 | -148% | -99 points |
| Q3 2024 | 6.9% | -11 points |
IMCC's operating margin was −28% last quarter, down 25 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over IMCC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over IMCC on profitability, with a higher operating margin.
IMCC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$927.5K | -$610.6K |
| Q1 2026 | -$134.3K | -104% |
| Q4 2025 | $1.9M | +$4.8M |
| Q3 2025 | -$2.5M | -231% |
| Q2 2025 | -$317K | -234% |
| Q1 2025 | $3.1M | +$3.6M |
| Q4 2024 | -$3M | -$2.8M |
| Q3 2024 | $1.9M | -50% |
IMCC has burned cash in most quarters: −$2M over the past year, against $2M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over IMCC on cash generation, producing positive trailing cash flow while its opponent burns cash.
IMCC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +22% | +35.5K shares |
| 1 year | +166% | +123K shares |
| 3 years | +680% | +172K shares |
IMCC has 197,633 diluted shares, up 166% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over IMCC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
IMCC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | 14.0x | High |
| Q4 2023 | 26.3x | High |
IMCC's net debt is about 14 years of its operating earnings (EBITDA).
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
IMCC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.7 | Oversold |
| Stochastic | 0.6 | Oversold |
IMCC's weekly RSI is 29 (oversold) and its Stochastic is 1 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
IMCC PE vs Healthcare Sector
IMCC has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
IMCC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.34 | 59% below |
| 20 week MA | $2.68 | 79% below |
| 50 week MA | $15.3 | 96% below |
| 100 week MA | $40.2 | 99% below |
| 200 week MA | $75.3 | 99% below |
IMCC is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over IMCC on trend strength, trading above more of its moving averages.
IMCC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3,556.8 | $15,120.0 | +325% |
| 2021 | $15,120.0 | $6,516.0 | -57% |
| 2022 | $6,516.0 | $189.0 | -97% |
| 2023 | $189.0 | $64.2 | -66% |
| 2024 | $64.2 | $73.2 | +14% |
| 2025 | $73.2 | $42.9 | -41% |
| 2026 YTD | $42.9 | $0.55 | -99% |
IMCC's yearly returns have swung widely, from +325% in 2020 to −97% in 2022. It's down 99% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over IMCC on returns for 2026, with the stronger performance.